Skip to main content
. 2022 Aug 9;11(16):4644. doi: 10.3390/jcm11164644

Table 3.

Cluster Analysis in high-risks patients.

Variable Cluster 1
n = 396
Cluster 2
n = 47
p
Origin (Urban) 299 (74.9) 36 (76.6) 0.8
Age (years) 61 (21) 77 (16) 0.00
Sex (women) 185 (46.4) 27 (57.4) 0.15
SARC-F (>4) 72 (16) 37 (78.7) 0.00
HBP 275 (68.9) 42 (89.4) 0.003
T2DM 169 (42.4) 25 (53.2) 0.15
Dyslipidemia 265 (66.4) 34 (72.3) 0.41
Hyperuricemia 75 (18) 19 (40.4) 0.0006
HF 57 (14.3) 27 (57.4) 0.0001
CAD 27 (6.7) 10 (21.3) 0.0006
Stroke 22 (5.5) 12 (25.5) 0.00
GERD 53 (13.3) 10 (21.3) 0.13
COPD/Asthma 43 (10.8) 5 (10.6) 0.97
Cancer 8 (2) 5 (10.6) 0.0009
Arthrosis 109 (27.3) 29 (61.7) 0.0001
Depression 78 (19.5) 17 (36.2) 0.008
Disability
Moderate 77 (19.3) 12 (25.5) 0.000
Severe 12 (3.01) 30 (63.8) 0.000
Comorbidities Charlson Index
Mild (0–1) 316 (79.2) 4 (8.5) 0.000
Moderate (2) 64 (16) 18 (38.3) 0.000
Severe (≥3) 19 (4.8) 25 (53.2) 0.000
BMI (kg/m2) 34.7 (6.6) 34.5 (8.89) 0.46
WC (cm) 112 (13.9) 116.3 (15.7) 0.02
FPG (mg/dL) 104 (32) 106.5 (37) 0.79
eGFR (mil/min/1.73 m2) 86.1 (30.4) 52.1 (42.4) 0.000
Uric acid (mg/dL) 5.8 (2.2) 7.4 (3.3) 0.00
hsCRP (mg/dL) 2.1 (4.5) 5.8 (4.1) 0.008
HDL-Chol (mg/dL) 46 (15) 48 (16) 0.63
LDL-Chol (mg/dL) 97 (51) 93 (67.5) 0.9
Triglycerides (mg/dL) 136 (87) 134.3 (72) 0.95
HbA1c (%) 5.9 (1.2) 6.3 (2) 0.05
AST (U/L) 23 (17) 15.5 (12.2) 0.001
ALT (U/L) 21 (12) 18 (7.5) 0.01
GGT (U/L) 31 (31) 35 (36.5) 0.11
ALP (U/L) 79 (35) 79.5 (37.5) 0.3
Hemoglobin (g/dL) 14.1 (2.3) 13 (2.2) 0.000
Leukocytes (×109/L) 7.4 (2.7) 8.3 (3.2) 0.007
Lymphocytes (×109/L) 2.2 (1) 1.9 (1.7) 0.33
Platelets (×109/L) 237 (95) 257 (115) 0.97
Albumin (mg/dL) 4.3 (0.5) 3.9 (0.7) 0.000
UACR (mg/g) 9 (17.8) 15 (38.2) 0.17
TyG index 4.1 (0.3) 4.1 (0.3) 0.91
C-reactive Protein/Albumin ratio (CAR) 0.5 (1.1) 1.3 (3.4) 0.01
Lymphocyte to CRP ratio (LCR) 0.925 (1.86) 0.52 (0.9) 0.002

Legend: ALP: alkaline phosphatase; ALT: Alanine transaminase; AST: Aspartate transaminase; BMI: body mass index; CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; eGFR: estimated glomerular filtration rate; FPG: fasting plasma glucose; FPG: Fasting plasma glucose; GERD: gastroesophageal reflux disease; GGT: Gamma-glutamyl transferase; HBP: high blood pressure; HbA1c: glycated hemoglobin; HDL: high density lipoprotein; hsCRP: high-sensitivity C-reactive protein; HF: heart failure; LDL: low density lipoprotein; T2DM: type 2 diabetes mellitus; UACR: Urinary albumin-to-creatinine ratio; SARC-F: Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls questionnaire; WC: waist circumference.